ADDvise receives order from AstraZeneca in China worth 1.3 MSEK.

ADDvise has received an order from AstraZeneca in Wuxi, China, to deliver laboratory furnishings and safety ventilation to a chemistry laboratory. The order amounts to 1.3 MSEK and will be delivered during 2016. The order will be delivered to AstraZeneca's research and development laboratory in Wuxi.

- This is the second order from AstraZeneca in Wuxi in a short time. It is exciting that we have continued confidence from AstraZeneca and that ADDvise products continue to be competitive in the Chinese market, says Rikard Akhtarzand CEO of ADDvise, in a comment on today's order.

 

For further information, please contact:

Rikard Akhtarzand, CEO, +46 765-25 90 71

rikard.akhtarzand@addvisegroup.se

www.addvisegroup.com

 

About ADDvise Group AB

ADDvise Group AB (publ) is an expansive group which through its subsidiaries IM-Medico Svenska AB, KEBO Inredningar Sverige AB, ADDvise Tillquist AB, Sonesta Medical AB, Sonesta Medical Inc and Surgical Tables Inc offers comprehensive solutions in the form of products and services to healthcare and research facilities. ADDvise Group's customers are located in both the private and public sectors. The Company's share is listed on First North Premier and Mangold Fondkommission AB, +46 8-503015 50, is the company's Certified Adviser and liquidity provider.